Skip to main navigation Skip to search Skip to main content

Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients

  • Yuh Shan Jou
  • , Yen Li Lo
  • , Chin Fu Hsiao
  • , Gee Chen Chang
  • , Ying Huang Tsai
  • , Wu Chou Su
  • , Yuh Min Chen
  • , Ming Shyan Huang
  • , Hui Ling Chen
  • , Chien Jen Chen
  • , Pan Chyr Yang
  • , Chao A. Hsiung*
  • *Corresponding author for this work
  • Academia Sinica - Institute of Biomedical Sciences
  • National Health Research Institutes Taiwan
  • Veterans General Hospital-Taichung Taiwan
  • National Cheng Kung University
  • Veterans General Hospital-Taipei
  • Kaohsiung Medical University
  • Academia Sinica - Genomics Research Center
  • National Taiwan University

Research output: Contribution to journal › Journal Article › peer-review

38 Scopus citations

Abstract

Epidermal growth factor receptor (EGFR) plays an important role in the development and progression of a variety of malignant tumors. To test single nucleotide polymorphisms (SNPs) and haplotypes of the EGFR in modulating the lung cancer susceptibility, we conducted a matched case-control study of 730 lung cancer patients and 730 healthy controls for examining the association in Taiwanese population. Fourteen tag SNPs distributed in EGFR were selected for genotyping and one SNP 8227G>A (rs763317) located in the intron 1 of EGFR was significantly associated with lung cancer (P = 0.009). Interestingly, the increase of lung cancer risk is significantly associated with never-smoking female adenocarcinoma patients harboring 8227A allele. In never-smoking female population, ORs for 8227G>A were significantly increased in adenocarcinoma subtype (adjusted odds ratio (OR) for GA genotype = 1.23, 95% confidence interval (CI) = 0.87-1.75; and adjusted OR for AA genotype = 3.52, 95% CI = 1.32-9.37, respectively). The ORs in dominant or recessive genetic model were also significantly increased in female lung adenocarcinoma subtype (adjusted OR = 1.35, 95% CI = 1.05-1.90; and adjusted OR = 3.26, 95% CI = 1.24-8.62, respectively). Haplotype analyses of 14 EGFR SNPs revealed that haplotype comprising the rare allele of 8227G>A and the common allele of the other 13 SNPs was associated with a significantly increased risk of female adenocarcinoma (OR = 2.81, 95% CI = 1.02-7.77). Together, our results suggest that polymorphisms or haplotypes of the EGFR play an important role in the development of lung cancer in Taiwan, particularly in never-smoking female lung adenocarcinoma.

Original languageEnglish
Pages (from-to)251-256
Number of pages6
JournalLung Cancer
Volume64
Issue number3
DOIs
StatePublished - 06 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • EGFR
  • Female adenocarcinoma
  • Lung cancer
  • Never-smoking
  • Polymorphism
  • Susceptibility

Fingerprint

Dive into the research topics of 'Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients'. Together they form a unique fingerprint.

Cite this